Viewing Study NCT02449603


Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2026-02-25 @ 9:50 PM
Study NCT ID: NCT02449603
Status: COMPLETED
Last Update Posted: 2018-11-14
First Post: 2015-05-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
Sponsor: Xijing Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chinese population View